Behavioural and histopathological alterations in mice with cerebral malaria
P. Lackner
Clinical Department of Neurology, Innsbruck Medical University, Innsbruck, Austria,
Search for more papers by this authorR. Beer
Clinical Department of Neurology, Innsbruck Medical University, Innsbruck, Austria,
Search for more papers by this authorV. Heussler
Department of Molecular Parasitology, Bernhard-Nocht-Institute for Tropical Medicine, Hamburg, Germany, and
Search for more papers by this authorG. Goebel
Department of Biostatistics and Documentation, Innsbruck Medical University, Innsbruck, Austria
Search for more papers by this authorD. Rudzki
Clinical Department of Neurology, Innsbruck Medical University, Innsbruck, Austria,
Search for more papers by this authorR. Helbok
Clinical Department of Neurology, Innsbruck Medical University, Innsbruck, Austria,
Search for more papers by this authorE. Tannich
Department of Molecular Parasitology, Bernhard-Nocht-Institute for Tropical Medicine, Hamburg, Germany, and
Search for more papers by this authorCorresponding Author
E. Schmutzhard
Clinical Department of Neurology, Innsbruck Medical University, Innsbruck, Austria,
Erich Schmutzhard, Innsbruck Medical University, Department of Neurology, 6020 Innsbruck, Anichstrasse 35, Austria. Tel: +43 512 504 23853; Fax: +43 512 504 24243; E-mail: [email protected]Search for more papers by this authorP. Lackner
Clinical Department of Neurology, Innsbruck Medical University, Innsbruck, Austria,
Search for more papers by this authorR. Beer
Clinical Department of Neurology, Innsbruck Medical University, Innsbruck, Austria,
Search for more papers by this authorV. Heussler
Department of Molecular Parasitology, Bernhard-Nocht-Institute for Tropical Medicine, Hamburg, Germany, and
Search for more papers by this authorG. Goebel
Department of Biostatistics and Documentation, Innsbruck Medical University, Innsbruck, Austria
Search for more papers by this authorD. Rudzki
Clinical Department of Neurology, Innsbruck Medical University, Innsbruck, Austria,
Search for more papers by this authorR. Helbok
Clinical Department of Neurology, Innsbruck Medical University, Innsbruck, Austria,
Search for more papers by this authorE. Tannich
Department of Molecular Parasitology, Bernhard-Nocht-Institute for Tropical Medicine, Hamburg, Germany, and
Search for more papers by this authorCorresponding Author
E. Schmutzhard
Clinical Department of Neurology, Innsbruck Medical University, Innsbruck, Austria,
Erich Schmutzhard, Innsbruck Medical University, Department of Neurology, 6020 Innsbruck, Anichstrasse 35, Austria. Tel: +43 512 504 23853; Fax: +43 512 504 24243; E-mail: [email protected]Search for more papers by this authorAbstract
Different features of sensorimotor function and behaviour were studied in murine cerebral malaria (CM) and malaria without cerebral involvement (non-CM) applying the primary screen of the SHIRPA protocol. Histopathological analysis of distinct brain regions was performed and the relative size of haemorrhages and plugging of blood cells to brain vasculature was analysed. Animals suffering from CM develop a wide range of behavioural and functional alterations in the progressive course of the disease with a statistically significant impairment in all functional categories assessed 36 h prior to death when compared with control animals. Early functional indicators of cerebral phenotype are impairments in reflex and sensory system and in neuropsychiatric state. Deterioration in function is paralleled by the degree of histopathological changes with a statistically significant correlation between the SHIRPA score of CM animals and the mean size of brain haemorrhage. Furthermore, image analysis yielded that the relative area of the brain lesions was significantly larger in the forebrain and brainstem compared with the other regions of interest. Our results indicate that assessment of sensory and motor tasks by the SHIRPA primary screen is appropriate for the early in vivo discrimination of cerebral involvement in experimental murine malaria. Our findings also suggest a correlation between the degree of functional impairment and the size of the brain lesions as indicated by parenchymal haemorrhage. Applying the SHIRPA protocol in the functional characterization of animals suffering from CM might prove useful in the preclinical assessment of new antimalarial and potential neuroprotective therapies.
References
- 1 WHO Expert Committee on Malaria. World Health Organ Tech Rep Ser 2000; 892: i–v, 1–74
- 2 De Souza JB, Riley EM. Cerebral malaria: the contribution of studies in animal models to our understanding of immunopathogenesis. Microbes Infect 2002; 4: 291–300
- 3 Hill AV, Allsopp CE, Kwiatkowski D, Anstey NM, Twumasi P, Rowe PA, Bennett S, Brewster D, McMichael AJ, Greenwood BM. Common west African HLA antigens are associated with protection from severe malaria. Nature 1991; 352: 595–600
- 4 McGuire W, Knight JC, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D. Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles. J Infect Dis 1999; 179: 287–90
- 5 Eling W, Van Zon A, Jerusalem C. The course of a Plasmodium berghei infection in six different mouse strains. Z Parasitenkd 1977; 54: 29–45
- 6 Pierrot C, Adam E, Lafitte S, Godin C, Dive D, Capron M, Khalife J. Age-related susceptibility and resistance to Plasmodium berghei in mice and rats. Exp Parasitol 2003; 104: 81–5
- 7 Amani V, Boubou MI, Pied S, Marussig M, Walliker D, Mazier D, Renia L. Cloned lines of Plasmodium berghei ANKA differ in their abilities to induce experimental cerebral malaria. Infect Immun 1998; 66: 4093–9
- 8 Engwerda CR, Mynott TL, Sawhney S, De Souza JB, Bickle QD, Kaye PM. Locally upregulated lymphotoxin alpha, not systemic tumor necrosis factor alpha, is the principle mediator of murine cerebral malaria. J Exp Med 2002; 195: 1371–7
- 9 Hansen DS, Siomos MA, Buckingham L, Scalzo AA, Schofield L. Regulation of murine cerebral malaria pathogenesis by CD1d-restricted NKT cells and the natural killer complex. Immunity 2003; 18: 391–402
- 10 Piguet PF, Kan CD, Vesin C, Rochat A, Donati Y, Barazzone C. Role of CD40-CVD40L in mouse severe malaria. Am J Pathol 2001; 159: 733–42
- 11 Jennings VM, Lal AA, Hunter RL. Evidence for multiple pathologic and protective mechanisms of murine cerebral malaria. Infect Immun 1998; 66: 5972–9
- 12 Grau GE, Fajardo LF, Piguet PF, Allet B, Lambert PH, Vassalli P. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science 1987; 237: 1210–12
- 13 Favre N, Da Laperousaz C, Ryffel B, Weiss NA, Imhof BA, Rudin W, Lucas R, Piguet PF. Role of ICAM-1 (CD54) in the development of murine cerebral malaria. Microbes Infect 1999; 1: 961–8
- 14 Coquelin F, Boulard Y, Mora-Silvera E, Richard F, Chabaud AG, Landau I. Final stage of maturation of the erythrocytic schizonts of rodent Plasmodium in the lungs. C R Acad Sci III 1999; 322: 55–62
- 15 Hearn J, Rayment N, Landon DN, Katz DR, De Souza JB. Immunopathology of cerebral malaria: morphological evidence of parasite sequestration in murine brain microvasculature. Infect Immun 2000; 68: 5364–76
- 16 Medana IM, Chan-Ling T, Hunt NH. Reactive changes of retinal microglia during fatal murine cerebral malaria: effects of dexamethasone and experimental permeabilization of the blood–brain barrier. Am J Pathol 2000; 156: 1055–65
- 17 Carvalho LJ, Lenzi HL, Pelajo-Machado M, Oliveira DN, Daniel-Ribeiro CT, Ferreirada- Cruz MF. Plasmodium berghei: cerebral malaria in CBA mice is not clearly related to plasma TNF levels or intensity of histopathological changes. Exp Parasitol 2000; 95: 1–7
- 18 Curfs JH, Schetters TP, Hermsen CC, Jerusalem CR, Van Zon AA, Eling WM. Immunological aspects of cerebral lesions in murine malaria. Clin Exp Immunol 1989; 75: 136–40
- 19 Ball HJ, MacDougall HG, McGregor IS, Hunt NH. Cyclooxygenase-2 in the pathogenesis of murine cerebral malaria. J Infect Dis 2004; 189: 751–8
- 20 Rogers DC, Fisher EM, Brown SD, Peters J, Hunter AJ, Martin JE. Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment. Mamm Genome 1997; 8: 711–13
- 21 Irwin S. Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse. Psychopharmacologia 1968; 13: 222–57
- 22 Hatcher JP, Virley D, Hadingham SJ, Roberts J, Hunter AJ, Parsons AA. The behavioural effect of middle cerebral artery occlusion on apolipoprotein-E deficient mice. Behav Brain Res 2002; 131: 139–49
- 23 Hunter AJ, Hatcher J, Virley D, Nelson P, Irving E, Hadingham SJ, Parsons AA. Functional assessments in mice and rats after focal stroke. Neuropharmacology 2000; 39: 806–16
- 24 Austrian Department of Health and Science. Guide for the care and use of laboratory animals. Federal Law Gazette 501/1989
- 25 Hatcher JP, Jones DN, Rogers DC, Hatcher PD, Reavill C, Hagan JJ, Hunter AJ. Development of SHIRPA to characterise the phenotype of gene-targeted mice. Behav Brain Res 2001; 125: 43–7
- 26 Paxinos G, Franklin K. The Mouse Brain in Stereotaxic Coordinates, 2nd edn. San Diego: Academic Press, 2003.
- 27 Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res 2001; 125: 279–84
- 28 Turner G. Cerebral malaria. Brain Pathol 1997; 7: 569–82
- 29 Norreel JC, Jamon M, Riviere G, Passage E, Fontes M, Clarac F. Behavioural profiling of a murine Charcot-Marie-Tooth disease type 1A model. Eur J Neurosci 2001; 13: 1625–34
- 30 Soothill JS, Morton DB, Ahmad A. The HID50 (hypothermia-inducing dose 50): an alternative to the LD50 for measurement of bacterial virulence. Int J Exp Pathol 1992; 73: 95–8
- 31 Zeman A. Consciousness. Brain 2001; 124: 1263–89
- 32 Warrell DA. Cerebral malaria: clinical features, pathophysiology and treatment. Ann Trop Med Parasitol 1997; 91: 875–84
- 33
Medana IM,
Chan-Ling T,
Hunt NH.
Redistribution and degeneration of retinal astrocytes in experimental murine cerebral malaria: relationship to disruption of the blood-retinal barrier.
Glia
1996; 16: 51–64
10.1002/(SICI)1098-1136(199601)16:1<51::AID-GLIA6>3.0.CO;2-E CAS PubMed Web of Science® Google Scholar
- 34 Dugbartey AT, Spellacy FJ, Dugbartey MT. Somatosensory discrimination deficits following pediatric cerebral malaria. Am J Trop Med Hyg 1998; 59: 393–6
- 35 Kochar DK, Makkar RK. Somatosensory evoked potentials in cerebral malaria. A preliminary study. Electromyogr Clin Neurophysiol 1994; 34: 301–7
- 36 Medana IM, Day NP, Hien TT, Mai NT, Bethell D, Phu NH, Farrar J, Esiri MM, White NJ, Turner GD. Axonal injury in cerebral malaria. Am J Pathol 2002; 160: 655–66
- 37 Pongponratn E, Riganti M, Punpoowong B, Aikawa M. Microvascular sequestration of parasitized erythrocytes in human falciparum malaria: a pathological study. Am J Trop Med Hyg 1991; 44: 168–75
- 38 Rogers DC, Jones DN, Nelson PR, Jones CM, Quilter CA, Robinson TL, Hagan JJ. Use of SHIRPA and discriminant analysis to characterise marked differences in the behavioural phenotype of six inbred mouse strains. Behav Brain Res 1999; 105: 207–17
- 39 Jennings VM, Actor JK, Lal AA, Hunter RL. Cytokine profile suggesting that murine cerebral malaria is an encephalitis. Infect Immun 1997; 65: 4883–7
- 40 Sanni LA. The role of cerebral oedema in the pathogenesis of cerebral malaria. Redox Rep 2001; 6: 137–42
- 41 Sanni LA, Rae C, Maitland A, Stocker R, Hunt NH. Is ischemia involved in the pathogenesis of murine cerebral malaria? Am J Pathol 2001; 159: 1105–12
- 42 Boonpucknavig V, Boonpucknavig S, Udomsangpetch R, Nitiyanant P. An immunofluorescence study of cerebral malaria. A correlation with histopathology. Arch Pathol Lab Med 1990; 114: 1028–34
- 43 Polder T, Jerusalem C, Eling W. Topographical distribution of the cerebral lesions in mice infected with Plasmodium berghei. Tropenmed Parasitol 1983; 34: 235–43
- 44 Neill AL, Hunt NH. Pathology of fatal and resolving Plasmodium berghei cerebral malaria in mice. Parasitology 1992; 105: 165–75
- 45 Ma N, Harding AJ, Pamphlett R, Chaudhri G, Hunt NH. Increased c-fos expression in the brain during experimental murine cerebral malaria: possible association with neurologic complications. J Infect Dis 1997; 175: 1480–9
- 46 Kaul DK, Nagel RL, Llena JF, Shear HL. Cerebral malaria in mice: demonstration of cytoadherence of infected red blood cells and microrheologic correlates. Am J Trop Med Hyg 1994; 50: 512–21
- 47 Riganti M, Pongponratn E, Tegoshi T, Looareesuwan S, Punpoowong B, Aikawa M. Human cerebral malaria in Thailand: a clinico-pathological correlation. Immunol Lett 1990; 25: 199–205
- 48 Newton CR, Hien TT, White N. Cerebral malaria. J Neurol Neurosurg Psychiatry 2000; 69: 433–41